Joel Habener, a winner of the Clinical Medical Research Award, is considered a pioneer in this field, having initiated research to discover the GLP-1 hormone in the 1980s
Brain health should also be incorporated, using cognitive testing and imaging to assess whether these therapies influence neurodegenerative risk
Glucagon-Like Peptide-1 Inhibits Angiotensin II-Induced Mesangial Cell Damage via Protein Kinase a
Providers can customize the program to fit their practices specific needs, adjusting everything from the educational content to daily tasks that keep patients accountable
At Klinic in Tulsa, we ease this process
Its ability to activate AMPK may help you achieve the same benefits as lifestyle modifications (i.e., exercise, dieting, and weight loss)